Lite Strategy, Inc. Total Liabilities
Lite Strategy, Inc. total liabilities. Based on the latest financial reports, Lite Strategy, Inc. (LITS) has total liabilities worth $1.07 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Lite Strategy, Inc. to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Lite Strategy, Inc. (2021–2025)
Total liabilities of Lite Strategy, Inc. from 2021 to 2025. This chart illustrates how Lite Strategy, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Lite Strategy, Inc. to see how much of total assets are deployed in long-term investments.
Lite Strategy, Inc. Competitors by Total Liabilities
The table below lists competitors of Lite Strategy, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CANEX Metals Inc
V:CANX
|
Canada | CA$319.77K |
|
OCA Acquisition Corp
NASDAQ:OCAX
|
USA | $15.99 Million |
|
Pembangunan Jaya Ancol Tbk
JK:PJAA
|
Indonesia | Rp1.65 Trillion |
|
Meditera Tibbi Malzeme Sanayi ve Ticaret AS
IS:MEDTR
|
Turkey | TL648.60 Million |
|
Touax SCA
PA:TOUP
|
France | €458.15 Million |
|
Global SM Tech Limited
KQ:900070
|
Korea | ₩35.90 Billion |
|
Aspocomp Group Oyj
HE:ACG1V
|
Finland | €10.21 Million |
|
Tower Real Estate Investment Trust
KLSE:5111
|
Malaysia | RM273.90 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Lite Strategy, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Lite Strategy, Inc. asset portfolio.
Liquidity & Leverage Metrics
Lite Strategy, Inc. Total Liabilities Ratios Explained
Lite Strategy, Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lite Strategy, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lite Strategy, Inc. (2021–2025)
The table below shows the annual total liabilities of Lite Strategy, Inc. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $1.35 Million | -83.79% |
| 2024-06-30 | $8.36 Million | -91.31% |
| 2023-06-30 | $96.19 Million | -23.31% |
| 2022-06-30 | $125.43 Million | +0.64% |
| 2021-06-30 | $124.63 Million | -- |
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.